Click for best price
Antibody Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 131700 million
|
Forecast Market size by 2029 |
US$ 237590 million
|
| Growth Rate |
CAGR of 8.8% |
Number of Pages |
74 Pages |
The global Antibody Drugs market was valued at US$ 131700 million in 2022 and is projected to reach US$ 237590 million by 2029, at a CAGR of 8.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Antibody Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Drugs. This report contains market size and forecasts of Antibody Drugs in global, including the following market information:
Global Antibody Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Antibody Drugs Market Sales, 2018-2023, 2024-2030, (mg)
Global top five Antibody Drugs companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Monoclonal Antibodies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Antibody Drugs include Novartis, Amgen, Bristol-Myers Squibb, F. Hoffmann-La Roche, Johnson & Johnson, AbbVie, Eli Lilly, Pfizer and Bayer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antibody Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antibody Drugs Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (mg)
Global Antibody Drugs Market Segment Percentages, by Type, 2022 (%)
- Monoclonal Antibodies
- Antibody-Drug Conjugates
- Polyclonal Antibodies
Global Antibody Drugs Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (mg)
Global Antibody Drugs Market Segment Percentages, by Application, 2022 (%)
- Central Nervous System (CNS) Disorders
- Cancers
- Autoimmune Disorders
- Cardiovascular Diseases
Global Antibody Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (mg)
Global Antibody Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Antibody Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Antibody Drugs revenues share in global market, 2022 (%)
- Key companies Antibody Drugs sales in global market, 2018-2023 (Estimated), (mg)
- Key companies Antibody Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novartis
- Amgen
- Bristol-Myers Squibb
- F. Hoffmann-La Roche
- Johnson & Johnson
- AbbVie
- Eli Lilly
- Pfizer
- Bayer
- GlaxoSmithKline
- Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antibody Drugs, market overview.
Chapter 2: Global Antibody Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Antibody Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antibody Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Antibody Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Antibody Drugs Market, Global Outlook and Forecast 2023-2030 |
| Market size in 2022 |
US$ 131700 million
|
| Forecast Market size by 2029 |
US$ 237590 million
|
| Growth Rate |
CAGR of 8.8% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antibody Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antibody Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antibody Drugs Overall Market Size
2.1 Global Antibody Drugs Market Size: 2022 VS 2030
2.2 Global Antibody Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Antibody Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Antibody Drugs Players in Global Market
3.2 Top Global Antibody Drugs Companies Ranked by Revenue
3.3 Global Antibody Drugs Revenue by Companies
3.4 Global Antibody Drugs Sales by Companies
3.5 Global Antibody Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Antibody Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Antibody Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antibody Drugs Players in Global Market
3.8.1 List of Global Tier 1 Antibody Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Antibody Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Antibody Drugs Market Size Markets, 2022 & 2030
4.1.2 Monoclonal Antibodies
4.1.3 Antibody-Drug Conjugates
4.1.4 Polyclonal Antibodies
4.2 By Type - Global Antibody Drugs Revenue & Forecasts
4.2.1 By Type - Global Antibody Drugs Revenue, 2018-2023
4.2.2 By Type - Global Antibody Drugs Revenue, 2024-2030
4.2.3 By Type - Global Antibody Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Antibody Drugs Sales & Forecasts
4.3.1 By Type - Global Antibody Drugs Sales, 2018-2023
4.3.2 By Type - Global Antibody Drugs Sales, 2024-2030
4.3.3 By Type - Global Antibody Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Antibody Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antibody Drugs Market Size, 2022 & 2030
5.1.2 Central Nervous System (CNS) Disorders
5.1.3 Cancers
5.1.4 Autoimmune Disorders
5.1.5 Cardiovascular Diseases
5.2 By Application - Global Antibody Drugs Revenue & Forecasts
5.2.1 By Application - Global Antibody Drugs Revenue, 2018-2023
5.2.2 By Application - Global Antibody Drugs Revenue, 2024-2030
5.2.3 By Application - Global Antibody Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Antibody Drugs Sales & Forecasts
5.3.1 By Application - Global Antibody Drugs Sales, 2018-2023
5.3.2 By Application - Global Antibody Drugs Sales, 2024-2030
5.3.3 By Application - Global Antibody Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Antibody Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Antibody Drugs Market Size, 2022 & 2030
6.2 By Region - Global Antibody Drugs Revenue & Forecasts
6.2.1 By Region - Global Antibody Drugs Revenue, 2018-2023
6.2.2 By Region - Global Antibody Drugs Revenue, 2024-2030
6.2.3 By Region - Global Antibody Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Antibody Drugs Sales & Forecasts
6.3.1 By Region - Global Antibody Drugs Sales, 2018-2023
6.3.2 By Region - Global Antibody Drugs Sales, 2024-2030
6.3.3 By Region - Global Antibody Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Antibody Drugs Revenue, 2018-2030
6.4.2 By Country - North America Antibody Drugs Sales, 2018-2030
6.4.3 US Antibody Drugs Market Size, 2018-2030
6.4.4 Canada Antibody Drugs Market Size, 2018-2030
6.4.5 Mexico Antibody Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Antibody Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Antibody Drugs Sales, 2018-2030
6.5.3 Germany Antibody Drugs Market Size, 2018-2030
6.5.4 France Antibody Drugs Market Size, 2018-2030
6.5.5 U.K. Antibody Drugs Market Size, 2018-2030
6.5.6 Italy Antibody Drugs Market Size, 2018-2030
6.5.7 Russia Antibody Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Antibody Drugs Market Size, 2018-2030
6.5.9 Benelux Antibody Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Antibody Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Antibody Drugs Sales, 2018-2030
6.6.3 China Antibody Drugs Market Size, 2018-2030
6.6.4 Japan Antibody Drugs Market Size, 2018-2030
6.6.5 South Korea Antibody Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Antibody Drugs Market Size, 2018-2030
6.6.7 India Antibody Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Antibody Drugs Revenue, 2018-2030
6.7.2 By Country - South America Antibody Drugs Sales, 2018-2030
6.7.3 Brazil Antibody Drugs Market Size, 2018-2030
6.7.4 Argentina Antibody Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antibody Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Antibody Drugs Sales, 2018-2030
6.8.3 Turkey Antibody Drugs Market Size, 2018-2030
6.8.4 Israel Antibody Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Antibody Drugs Market Size, 2018-2030
6.8.6 UAE Antibody Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Antibody Drugs Major Product Offerings
7.1.4 Novartis Antibody Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Antibody Drugs Major Product Offerings
7.2.4 Amgen Antibody Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Antibody Drugs Major Product Offerings
7.3.4 Bristol-Myers Squibb Antibody Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Company Summary
7.4.2 F. Hoffmann-La Roche Business Overview
7.4.3 F. Hoffmann-La Roche Antibody Drugs Major Product Offerings
7.4.4 F. Hoffmann-La Roche Antibody Drugs Sales and Revenue in Global (2018-2023)
7.4.5 F. Hoffmann-La Roche Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Antibody Drugs Major Product Offerings
7.5.4 Johnson & Johnson Antibody Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 AbbVie
7.6.1 AbbVie Company Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Antibody Drugs Major Product Offerings
7.6.4 AbbVie Antibody Drugs Sales and Revenue in Global (2018-2023)
7.6.5 AbbVie Key News & Latest Developments
7.7 Eli Lilly
7.7.1 Eli Lilly Company Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Antibody Drugs Major Product Offerings
7.7.4 Eli Lilly Antibody Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Eli Lilly Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Antibody Drugs Major Product Offerings
7.8.4 Pfizer Antibody Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Bayer
7.9.1 Bayer Company Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Antibody Drugs Major Product Offerings
7.9.4 Bayer Antibody Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Bayer Key News & Latest Developments
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Company Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Antibody Drugs Major Product Offerings
7.10.4 GlaxoSmithKline Antibody Drugs Sales and Revenue in Global (2018-2023)
7.10.5 GlaxoSmithKline Key News & Latest Developments
7.11 Sanofi
7.11.1 Sanofi Company Summary
7.11.2 Sanofi Antibody Drugs Business Overview
7.11.3 Sanofi Antibody Drugs Major Product Offerings
7.11.4 Sanofi Antibody Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Sanofi Key News & Latest Developments
8 Global Antibody Drugs Production Capacity, Analysis
8.1 Global Antibody Drugs Production Capacity, 2018-2030
8.2 Antibody Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Antibody Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Antibody Drugs Supply Chain Analysis
10.1 Antibody Drugs Industry Value Chain
10.2 Antibody Drugs Upstream Market
10.3 Antibody Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antibody Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Antibody Drugs in Global Market
Table 2. Top Antibody Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Antibody Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Antibody Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Antibody Drugs Sales by Companies, (mg), 2018-2023
Table 6. Global Antibody Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Antibody Drugs Price (2018-2023) & (USD/mg)
Table 8. Global Manufacturers Antibody Drugs Product Type
Table 9. List of Global Tier 1 Antibody Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibody Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Antibody Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Antibody Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Antibody Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Antibody Drugs Sales (mg), 2018-2023
Table 15. By Type - Global Antibody Drugs Sales (mg), 2024-2030
Table 16. By Application ? Global Antibody Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Antibody Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Antibody Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Antibody Drugs Sales (mg), 2018-2023
Table 20. By Application - Global Antibody Drugs Sales (mg), 2024-2030
Table 21. By Region ? Global Antibody Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Antibody Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Antibody Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Antibody Drugs Sales (mg), 2018-2023
Table 25. By Region - Global Antibody Drugs Sales (mg), 2024-2030
Table 26. By Country - North America Antibody Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Antibody Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Antibody Drugs Sales, (mg), 2018-2023
Table 29. By Country - North America Antibody Drugs Sales, (mg), 2024-2030
Table 30. By Country - Europe Antibody Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Antibody Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Antibody Drugs Sales, (mg), 2018-2023
Table 33. By Country - Europe Antibody Drugs Sales, (mg), 2024-2030
Table 34. By Region - Asia Antibody Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Antibody Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Antibody Drugs Sales, (mg), 2018-2023
Table 37. By Region - Asia Antibody Drugs Sales, (mg), 2024-2030
Table 38. By Country - South America Antibody Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Antibody Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Antibody Drugs Sales, (mg), 2018-2023
Table 41. By Country - South America Antibody Drugs Sales, (mg), 2024-2030
Table 42. By Country - Middle East & Africa Antibody Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Antibody Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Antibody Drugs Sales, (mg), 2018-2023
Table 45. By Country - Middle East & Africa Antibody Drugs Sales, (mg), 2024-2030
Table 46. Novartis Company Summary
Table 47. Novartis Antibody Drugs Product Offerings
Table 48. Novartis Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Antibody Drugs Product Offerings
Table 52. Amgen Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Bristol-Myers Squibb Company Summary
Table 55. Bristol-Myers Squibb Antibody Drugs Product Offerings
Table 56. Bristol-Myers Squibb Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2018-2023)
Table 57. Bristol-Myers Squibb Key News & Latest Developments
Table 58. F. Hoffmann-La Roche Company Summary
Table 59. F. Hoffmann-La Roche Antibody Drugs Product Offerings
Table 60. F. Hoffmann-La Roche Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2018-2023)
Table 61. F. Hoffmann-La Roche Key News & Latest Developments
Table 62. Johnson & Johnson Company Summary
Table 63. Johnson & Johnson Antibody Drugs Product Offerings
Table 64. Johnson & Johnson Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2018-2023)
Table 65. Johnson & Johnson Key News & Latest Developments
Table 66. AbbVie Company Summary
Table 67. AbbVie Antibody Drugs Product Offerings
Table 68. AbbVie Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2018-2023)
Table 69. AbbVie Key News & Latest Developments
Table 70. Eli Lilly Company Summary
Table 71. Eli Lilly Antibody Drugs Product Offerings
Table 72. Eli Lilly Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2018-2023)
Table 73. Eli Lilly Key News & Latest Developments
Table 74. Pfizer Company Summary
Table 75. Pfizer Antibody Drugs Product Offerings
Table 76. Pfizer Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2018-2023)
Table 77. Pfizer Key News & Latest Developments
Table 78. Bayer Company Summary
Table 79. Bayer Antibody Drugs Product Offerings
Table 80. Bayer Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2018-2023)
Table 81. Bayer Key News & Latest Developments
Table 82. GlaxoSmithKline Company Summary
Table 83. GlaxoSmithKline Antibody Drugs Product Offerings
Table 84. GlaxoSmithKline Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2018-2023)
Table 85. GlaxoSmithKline Key News & Latest Developments
Table 86. Sanofi Company Summary
Table 87. Sanofi Antibody Drugs Product Offerings
Table 88. Sanofi Antibody Drugs Sales (mg), Revenue (US$, Mn) and Average Price (USD/mg) (2018-2023)
Table 89. Sanofi Key News & Latest Developments
Table 90. Antibody Drugs Production Capacity (mg) of Key Manufacturers in Global Market, 2021-2023 (mg)
Table 91. Global Antibody Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Antibody Drugs Production by Region, 2018-2023 (mg)
Table 93. Global Antibody Drugs Production by Region, 2024-2030 (mg)
Table 94. Antibody Drugs Market Opportunities & Trends in Global Market
Table 95. Antibody Drugs Market Drivers in Global Market
Table 96. Antibody Drugs Market Restraints in Global Market
Table 97. Antibody Drugs Raw Materials
Table 98. Antibody Drugs Raw Materials Suppliers in Global Market
Table 99. Typical Antibody Drugs Downstream
Table 100. Antibody Drugs Downstream Clients in Global Market
Table 101. Antibody Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Antibody Drugs Segment by Type in 2022
Figure 2. Antibody Drugs Segment by Application in 2022
Figure 3. Global Antibody Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Antibody Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Antibody Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Antibody Drugs Sales in Global Market: 2018-2030 (mg)
Figure 8. The Top 3 and 5 Players Market Share by Antibody Drugs Revenue in 2022
Figure 9. By Type - Global Antibody Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Antibody Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Antibody Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global Antibody Drugs Price (USD/mg), 2018-2030
Figure 13. By Application - Global Antibody Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Antibody Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global Antibody Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global Antibody Drugs Price (USD/mg), 2018-2030
Figure 17. By Region - Global Antibody Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Antibody Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Antibody Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global Antibody Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America Antibody Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America Antibody Drugs Sales Market Share, 2018-2030
Figure 23. US Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Antibody Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Antibody Drugs Sales Market Share, 2018-2030
Figure 28. Germany Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Antibody Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Antibody Drugs Sales Market Share, 2018-2030
Figure 37. China Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Antibody Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America Antibody Drugs Sales Market Share, 2018-2030
Figure 44. Brazil Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Antibody Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Antibody Drugs Sales Market Share, 2018-2030
Figure 48. Turkey Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Antibody Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global Antibody Drugs Production Capacity (mg), 2018-2030
Figure 53. The Percentage of Production Antibody Drugs by Region, 2022 VS 2030
Figure 54. Antibody Drugs Industry Value Chain
Figure 55. Marketing Channels
